Response - Proposal Ext.pdf

This solicitation requests proposals for the acquisition of medical countermeasures for pandemic influenza and emerging diseases preparedness and response. Key details include that the base period of performance is anticipated for thirty-six months from date of award, with the potential for up to an additional twenty-four months of performance through exercised option periods. Seventeen contract line items are specified, covering activities such as the provision of master and working seed lots for influenza vaccine, investigational and commercial scale vaccine lots, adjuvant bulk product, formulation and filling services, storage and stability services, shipping, potency testing, and emerging pathogen response. Proposals are due by September 13, 2021 with the goal of awarding a new IDIQ contract by February 21, 2022. Pricing is requested as firm-fixed-price for all CLINs except those specified as TBD or N/A. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response is the issuing agency.